Menu
Exonate
Exonate develops and licenses Vascular Endothelial Growth Factors (VEGF) control agents that may be used as therapeutics in areas such as pain control, macular degeneration and cancer.
Drug discovery – wet AMD and cancer
School of Medicine
Profile
Exonate’s research in this area has identified therapeutic candidates for wet Age Related Macular Degeneration that can be administered as a simple eye drop, thereby over-coming the unpleasant need for monthly injections in the eye.
Competing injectable anti-VEGFdirected therapy currently constitutes the gold-standard treatment for wet Age Related Macular Degeneration (wAMD) and other neovascular diseases of the eye.
News and press releases
@ExonateUK on Twitter
At Janssen, we dare to envision a world where retinal diseases are a thing of the past. We're pioneering courageous science with the goal of restoring and preserving vision for people around the world living with retinal diseases.
Learn more: https://bit.ly/JanssenRetina
13-19th June 2022 is Diabetes week, the theme is celebrating each and every one of you. Recognising that 1 in 14 people are affected by Diabetes.
Find out how you get involved at Diabetes UK
#DiabetesWeek2022 #DiabetesUK #DiabetesWeek
Join us this #DiabetesWeek to hear from some very special guests, as we discuss some of the highs and the lows of living with diabetes:
📆 Tuesday 14 June
⏰ 6pm
📍 Live via our Facebook page: https://orlo.uk/q2nBm
We hope you to see you there! 💙
❗ 4.9 million of us live with diabetes. And every one of us matters.
This #DiabetesWeek, we’re calling on decision makers across the UK to stand with us & do more for people affected by diabetes.
📢 Let’s make a noise they can’t ignore. Sign & share our petition by 19 June!
Diabetes Week is here! To celebrate we're spotlighting our newest e-learning module, 'Understanding Diabetes', part of our CPD online platform. Check out our free, self-paced, 90 minute module for non-specialist HCPs to increase your knowledge and skills: https://orlo.uk/understanding_diabetes_yqAml
It's the start of #DiabetesWeek! 🎉
👀 Keep an eye on our socials all week where we'll be busting myths, matching your donations, and sharing stories of real people living with #type1diabetes.
#GBDoc #T1D
Diabetic retinopathy is a complication of diabetes, caused by high blood sugar levels damaging the retina.
It affects up to 8 out of 10 patients who have had diabetes for 10 years or more. #DiabetesWeek
